logo
episode-header-image
Mar 2026
16m 6s

Niklas Mattsson-Carlgren on the use of b...

The Lancet Group
About this episode
In this episode, Laura Hart and Elena Becker-Barroso speak with Niklas Mattsson-Carlgren (Lund University) about the use of blood biomarkers in the diagnosis and stratification of Alzheimer's disease. They discuss two particular plasma biomarkers—p-tau217 and eMTBR-tau243—including what they measure and how a proposed practical two-step approach that uses p- ... Show More
Up next
Jun 17
Hal Dietz discusses the role of genetics in spinal CSF leaks
In this episode of In Conversation With, Morgane Boillot, Senior Editor at The Lancet Neurology, speaks with connective tissue disorders — including Marfan syndrome — and human genetics expert Hal Dietz from Johns Hopkins Medicine (Baltimore, USA) about the genetics of spontaneou ... Show More
16m 23s
Jun 16
Tony Schapira on GBA1 Parkinson's disease
In this episode of In Conversation With, Elena Becker-Barroso, Editor-in-Chief of The Lancet Neurology, speaks with movement disorders specialist Tony Schapira from UCL’s Queen Square Institute of Neurology about GBA1-associated Parkinson’s disease. Together, they explore the gen ... Show More
26m 5s
Apr 17
Henry Brodaty and Alice Powell on cognitive resilience and ageing
Join The Lancet Neurology’s In Conversation With… as editors Elena Becker-Barroso and Laura Hart welcome Henry Brodaty and Alice Powell from the University of New South Wales (Sydney, Australia) to discuss cognitive resilience and ageing. This episode teases apart cognitive resil ... Show More
23m 11s
Recommended Episodes
Jul 2024
Tapping the Brakes on New Parkinson Disease Biological Staging
Dr. Matthew Barrett talks with Dr. Michael S. Okun about the caution and deliberation needed in understanding Parkinson disease biomarkers. Read the related viewpoint piece in JAMA Neurology. Disclosures can be found at Neurology.org. 
17m 45s
Feb 2024
The 2 Minute Medicine® Podcast- Episode 35
<p>We begin with a discussion about our article of the week which comes from The Lancet and is entitled “Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-c ... Show More
11m 48s
Jul 2024
Large Language Models for Quality and Efficiency of Neurologic Care
Dr. Andy Southerland talks with Dr. Lidia Moura about the implications of large language models (LLMs) for neurologic care. Read the related article in Neurology. Disclosures can be found at Neurology.org. 
22m 50s
May 2023
Biomarker and Treatment Development in Movement Disorders
<p>Dr. Jason Crowell talks with Prof. Bastiaan Bloem about the latest developments in biomarkers and treatments for movement disorders, which have been described in numerous research papers from 2022. </p> <p>Read the related article in <a href= "https://www.thelancet.com/journal ... Show More
17m 12s
Jan 2022
Alzheimer Disease: Diffusion Tensor MRI and amyloid PET
Dr. Manisha Bahl interviews Dr. Jeffrey Prescott. Diffuse Tensor MRI Structural Connectivity and PET Amyloid Burden in Preclinical Autosomal Dominant Alzheimer Disease: The DIAN Cohort. Prescott et al. Radiology 2022; 302:143–150.  
11m 41s
Jan 2025
Superhuman Performance of a LLM on the Reasoning Tasks of a Physician
Dr. Andy Southerland talks with Dr. Adam Rodman about the implications of large language models in clinical reasoning and diagnostics. Read the related article on arXiv.  Disclosures can be found at Neurology.org. 
18m 13s
Feb 2024
Vascular Risk Factors and Biomarker Association With White Matter Hyperintensities in American Football Players
Dr. Shuvro Roy talks with Dr. Monica T. Ly about brain lesions in former football players linked to vascular brain changes. Read the related article in Neurology. Disclosures can be found at Neurology.org. 
16m 37s
Nov 2024
Genetic Leukodystrophies Mimicking CNS Inflammation - Part 2
In the concluding segment of this two-part series, Dr. Justin Abbatemarco talks with Dr. Jennifer L. Orthmann-Murphy about genetic leukodystrophies and the increasing recognition of these disorders in adult neurology, the importance of genetic testing, and the evolving treatment ... Show More
13m 12s
Feb 2023
Dementia and Mild Cognitive Impairment
Dr. Kenneth Langa discusses his paper, "Estimating the Prevalence of Dementia and Mild Cognitive Impairment in the US". Show references: https://jamanetwork.com/journals/jamaneurology/article-abstract/2797274?resultClick=1 This episode is brought to you by Mass General Brigham De ... Show More
1m 53s
Jun 2024
Mortality in a Danish NMO Cohort
Dr. Justin Abbatemarco talks with Prof. Zsolt Illes about the mortality of patients with AQP4 antibody–seropositive neuromyelitis optica spectrum disorder compared with that in the general population. Read the related article in Neurology.  This podcast is sponsored by argenx. Vi ... Show More
18m 40s